European Companies Search Engine

Wordmark: “DRIES BETTER“ Euipotm 2 Dec 2019 European Union Intellectual Property Office (Trade Marks)

History

Text

Trade mark

Type Word
Name DRIES BETTER
Filing number 018091006
Trade mark status REGISTERED
Nice Classification

5: Pharmaceutical preparations.

9: Downloadable software in the nature of a mobile application for providing information relating to the treatment of ophthalmic diseases and disorders.

35: Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services; business administration of pharmacy reimbursement programs and services.

41: Educational and training services, namely conducting classes, seminars, workshops, etc in the field of ophthalmic diseases and disorders; providing online non-downloadable publications in the nature of articles, books and journals in the field of ophthalmic diseases and disorders and the monitoring and management of said diseases and disorders.

42: Providing temporary use of a non-downloadable web application for processing patient information related to ophthalmology.

44: Providing medical information in the field of ophthalmic diseases and disorders; medical services, namely assisting in the observation, monitoring, adherence and compliance of patients to medical treatments; doctor's appointment reminder services pertaining to patient visits to doctors, medical centers and specialists such as ophthalmologists.

45: Organizing and conducting support groups in the field of ophthalmology; Social networking services in the field of ophthalmological diseases and disorders and the monitoring and management of said diseases and disorders provided via a website.

Filing date 03/07/2019
Registration date 27/11/2019
Expiry date 03/07/2029
Owners

Novartis AG

c/o Novartis Pharma AG

Trademark Department

CH-4002 Basel

Switzerland

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Novartis AG, Basle, Switzerland.